Galmed Pharmaceuticals Return on Assets (ROA) Growth & History (GLMD)

Galmed Pharmaceuticals's return on assets (roa) was −55.53% for fiscal 2025.

View full Galmed Pharmaceuticals company overview

Galmed Pharmaceuticals annual return on assets (roa) history

Galmed Pharmaceuticals annual return on assets (roa)

Fiscal yearPeriod endedReturn on assets (ROA)Change (percentage points)
20252025-12-31−55.53%−12.74 pp
20242024-12-31−42.80%−1.15 pp
20232023-12-31−41.65%+25.56 pp
20222022-12-31−67.21%+5.76 pp
20212021-12-31−72.97%−28.54 pp
20202020-12-31−44.43%−20.03 pp
20192019-12-31−24.40%−6.52 pp
20182018-12-31−17.88%+50.27 pp
20172017-12-31−68.15%+15.13 pp
20162016-12-31−83.28%−46.13 pp
20152015-12-31−37.15%+17.87 pp
20142014-12-31−55.02%

Galmed Pharmaceuticals return on assets (roa) trends

Over the last five fiscal years, Galmed Pharmaceuticals's return on assets (roa) decreased from −44.43% to −55.53%, a change of −11.11 percentage points. The latest reported quarter, Q2 2026, shows −55.03%.

About the metric

What return on assets means

Return on assets measures profit relative to the assets used to generate it. It can help compare operating efficiency over time, although normal ROA differs substantially between asset-light and asset-intensive industries.

Calculation and source

How return on assets is calculated

TickerStat calculates annual ROA as reported net income divided by average total assets. Quarterly observations use trailing-12-month net income and average assets over the corresponding one-year period. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Galmed Pharmaceuticals source filings ↗

Community posts

It’s quiet here.

No posts about GLMD yet. Start the conversation.

Write the first post